Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
MAbs. 2019 Aug/Sep;11(6):1175-1190. doi: 10.1080/19420862.2019.1624463. Epub 2019 Jun 10.
MAbs. 2019.
PMID: 31181988
Free PMC article.
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.
Liu L, Lu J, Allan BW, Tang Y, Tetreault J, Chow CK, Barmettler B, Nelson J, Bina H, Huang L, Wroblewski VJ, Kikly K.
Liu L, et al. Among authors: barmettler b.
J Inflamm Res. 2016 Apr 19;9:39-50. doi: 10.2147/JIR.S100940. eCollection 2016.
J Inflamm Res. 2016.
PMID: 27143947
Free PMC article.
Item in Clipboard
A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases.
Boyles JS, Sadowski D, Potter S, Vukojicic A, Parker J, Chang WY, Ma YL, Chambers MG, Nelson J, Barmettler B, Smith EM, Kersjes K, Himes ER, Lin C, Lucchesi J, Brahmbhatt J, Sina R, Martin JA, Maestri E, Wiethoff CM, Dyas GL, Linnik MD, Na S, Witcher DR, Budelsky A, Rubtsova K.
Boyles JS, et al. Among authors: barmettler b.
JCI Insight. 2023 Jul 10;8(13):e166137. doi: 10.1172/jci.insight.166137.
JCI Insight. 2023.
PMID: 37427592
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.